Strategic Acquisition Upsell Steady Health was acquired by Carbon Health in 2021, which may open opportunities to bundle diabetes management with broader care platforms, cross-sell CGM-driven endocrinology services, and leverage Carbon Health’s network for enterprise or payer collaborations.

CGM Powered Care The core value proposition revolves around continuous glucose monitoring integrated with telemedicine. This suggests opportunities to pitch expanded CGM device partnerships, data-driven diabetes programs for employers, and expanded remote monitoring offerings to health plans and clinics.

Partnership Proof Points Past collaboration with Dexcom demonstrates openness to platform integrations. Sales targets could include partnerships with additional CGM/medical device manufacturers and integration-ready health tech platforms to scale adoption in employer and payer channels.

Market Positioning As a pioneer in a fully digital diabetes clinic with a lean team, there is potential to target mid-market employers and health systems seeking scalable, telemedicine–enabled diabetes care solutions, leveraging the lean cost structure and digital-first approach.

Growth Opportunities With modest revenue in the lower multi‑million range and a recent acquisition backdrop, there is room to pursue expansion into preventive care analytics, population health programs, and grantee or grant-funded pilots that emphasize CGM data-driven outcomes.